在帕金森症子中,底核的血清激素内置
C V L Delmas1, J Munro1, M Bérard1
1CERVO Brain Research Center and Department of Psychiatry and Neuroscience, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada.
Neurobiology of disease
|May 4, 2025
概括
帕金森病 (PD) 改变了血清素 (5-HT) 的大脑通路. 在帕金森症子中,下核 (STN) 中的5-HT轴突具有较少但较大的静脉,可能降低5-HT水平以弥补STN过度兴奋性.
科学领域:
- 神经科学是一个神经科学.
- 神经解剖学是一个神经解剖学.
- 帕金森病研究 帕金森病研究
背景情况:
- 亚thalamic核 (STN) 对于基底腺功能至关重要.
- 血清素 (5-HT) 向STN的投射已知具有可塑性.
- 改变的STN神经元发射是帕金森病 (PD) 的特征.
研究的目的:
- 在帕金森症子模型中研究5-HT输入到STN中的神经适应性变化.
- 在STN的功能区域内对5-HT轴突变形状的改变进行表征.
主要方法:
- 在MPTP诱导的帕金森症和对照性子中利用光和电子显微镜.
- 采用了无偏见的立体学来量化标记为SERT的5-HT轴突变性.
- 评估了轴突的长度和背部拉菲核神经元数量.
主要成果:
- 在所有STN地区,MPTP治疗显著降低了SERT+ 5-HT轴突变脉的密度.
- 与对照人群相比,MPTP治疗的子的静脉变更大.
- 5-HT轴突的长度和背部拉菲核神经元数量仍然保持不变.
- 在这两组中,很大一部分静脉是非突触的.
结论:
- 帕金森氏症子在STN中表现出保存的5-HT轴突,但减少了变形状的数量.
- 这种变形体的减少可能导致STN中的环境5-HT水平降低.
- 这种变化可能是对STN神经元过敏性在PD中的补偿机制.
更多相关视频
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.5K
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.6K
相关概念视频
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Treatment
170
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
170
Parkinson's Disease: Overview
405
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
405
